Journal Title
ChemMedChem

CHEMMEDCHEM

ISSN / eISSN
1860-7179 / 1860-7187
Aims and Scope
Quality research. Outstanding publications. With an impact factor of 3.124 (2019), ChemMedChem is a top journal for research at the interface of chemistry, biology and medicine. It is published on behalf of Chemistry Europe, an association of 16 European chemical societies.

ChemMedChem publishes primary as well as critical secondary and tertiary information from authors across and for the world. Its mission is to integrate the wide and flourishing field of medicinal and pharmaceutical sciences, ranging from drug design and discovery to drug development and delivery, from molecular modeling to combinatorial chemistry, from target validation to lead generation and ADMET studies. ChemMedChem typically covers topics on small molecules, therapeutic macromolecules, peptides, peptidomimetics, and aptamers, protein-drug conjugates, nucleic acid therapies, and beginning 2017, nanomedicine, particularly 1) targeted nanodelivery, 2) theranostic nanoparticles, and 3) nanodrugs.

Contents
ChemMedChem publishes an attractive mixture of:

Full Papers and Communications
Reviews and Minireviews
Patent Reviews
Highlights and Concepts
Book and Multimedia Reviews.
Subject Area

CHEMISTRY, MEDICINAL

PHARMACOLOGY & PHARMACY

CiteScore
5.60 View Trend
CiteScore Ranking
Category Quartile Rank
Pharmacology, Toxicology and Pharmaceutics - General Pharmacology, Toxicology and Pharmaceutics Q1 #9/79
Pharmacology, Toxicology and Pharmaceutics - Organic Chemistry Q2 #65/197
Pharmacology, Toxicology and Pharmaceutics - Pharmacology Q2 #123/301
Pharmacology, Toxicology and Pharmaceutics - Drug Discovery Q2 #70/156
Pharmacology, Toxicology and Pharmaceutics - Biochemistry Q2 #199/428
Pharmacology, Toxicology and Pharmaceutics - Molecular Medicine Q3 #90/171
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2023) Quartile
CHEMISTRY, MEDICINAL - SCIE Q3
PHARMACOLOGY & PHARMACY - SCIE Q2
H-index
92
Country/Area of Publication
GERMANY
Publisher
John Wiley and Sons Ltd
Publication Frequency
Monthly
Year Publication Started
2006
Annual Article Volume
224
Open Access
NO
Contact
WILEY-V C H VERLAG GMBH, PO BOX 10 11 61, WEINHEIM, GERMANY, D-69451
Verified Reviews
Note: Verified reviews are sourced from across review platforms and social media globally.
The first round of review took a whole month, with two reviewers providing contrasting evaluations - one negative and one positive. The editor suggested in the letter that the paper could be submitted to Chemistry Select and also mentioned the possibility of seeking additional reviewers. After requesting a third reviewer from another country, the process sped up significantly. The following day, the status changed to "peer review," and after 10 days, feedback was received. The third reviewer recommended language polishing. After one week of language polishing, the paper was accepted.
2021-05-24
It takes about 10 days to transition from an editor to a reviewer. Within 7 days, they send minor revision comments. After replying to the comments, it takes only 3 days for temporary acceptance. It took less than a month from submission to acceptance. It's just that this year's demotion is very difficult to bear.
2023-02-19

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started